Skip to main content
Premium Trial:

Request an Annual Quote

Invitae to Raise $400M in Proposed Public Offering

NEW YORK – Invitae announced after the close of the market Wednesday that it aims to raise $400 million through an underwritten public offering of nearly 7.2 million shares of its common stock based on an assumed price of $55.86 per share.

The company estimated the number of shares it expects to sell based on the price of its common stock on the New York Stock Exchange on Jan. 19. Additionally, Invitae said it will give underwriters a 30-day option to purchase $60 million in additional shares of its common stock at the public offering price, minus underwriting discounts and expenses.

JP Morgan Securities, Morgan Stanley, Cowen, and SVB Leerink are acting as the book-running managers for the proposed offering.

Invitae plans to use the proceeds for working capital, improving its platform, expanding its oncology and reproductive testing products, and growing its international presence. A portion of the funds might also go toward acquiring other businesses and technologies.  

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.